Login / Signup

Obesity, Sarcopenia and Myosteatosis: Impact on Clinical Outcomes in the Operative Management of Crohn's Disease.

Mark DonnellyDorothee DrieverÉanna J RyanJessie A ElliottJohn FinneganDeirdre McNamaraIan MurphyKevin C ConlonPaul C NearyDara O KavanaghJames M O'Riordan
Published in: Inflammatory bowel diseases (2023)
Myosteatosis is associated with nutritional impairment and predicts increased overall postoperative morbidity following resection for CD. Despite its association with specific increased postoperative risks, increased adiposity does not increase overall morbidity, reflecting preservation of nutritional status and relatively more quiescent disease phenotype. Impaired muscle mass and function represent an appealing target for patient optimization to improve outcomes in the surgical management of CD.
Keyphrases
  • insulin resistance
  • patients undergoing
  • metabolic syndrome
  • type diabetes
  • weight gain
  • weight loss
  • skeletal muscle
  • body mass index
  • physical activity
  • risk assessment
  • climate change
  • glycemic control